CTRI/2019/07/020313尚未招募4 期
Role of ulinastatin in severe acute pancreatitis - a randomized controlled study
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients aged 18 - 80 years with severe acute pancreatitis presenting to Lok Nayak Hospital
排除标准
- •1. Mild pancreatitis
- •2. Pregnancy
- •3. Lactation
- •4. Allergy to ulinastatin
- •5. Chronic pancreatitis
- •6. Traumatic pancreatitis
研究者
相似试验
进行中（未招募）
3 期
The effect of ulinastatin on sepsis-related organ failure in childreInfections and InfestationsSepsisISRCTN15982148Guangdong Techpool Bio-pharma Co., Ltd.364
Unknown
3 期
Clinical Efficacy of Ulinastatin for Treatment of Sepsis With Systemic Inflammatory Response SyndromeSepsisNCT05391789Huashan Hospital120
Unknown
2 期
Secretin for Acute PancreatitisPancreatitis, AcuteNCT03686618ChiRhoClin, Inc.40
招募中
4 期
An interventional trial to assess the efficacy of ulinastatin to reduce the number of days stayed in Intensive Care Unit and in the hospital for patients diagnosed with acute severe to moderately severe pancreatitis.CTRI/2024/07/070450SRMMCH and RC Kattankulathur campus
已完成
不适用
Impact of Anamorelin with unresectable pancreatic, gastric and colorectal cancer patients for a quality of life, skeletal muscle index and malnutritioPancreatic cancer Gastric cancer Colorectal cancerJPRN-UMIN000045611Asahikawa Medical University Department of Medicine, Division of Metabolism and Biosystemic Science, Gastroenterology, and Hematology194